针对CD7的亲细胞亡细胞外囊泡:T细胞血液恶性瘤治疗的新方法
Bei Zhang1,2, Jianqiang Chen1, Jiming Chen3,4,5
1Department of Orthopaedics of the Second Affiliated Hospital and Institute of Immunology, Zhejiang University School of Medicine, Hangzhou, China.
Journal of extracellular vesicles
|December 16, 2024
概括
这项研究介绍了一种新的药物递送系统,使用工程外细胞囊泡 (EV) 向CD7+T细胞恶性瘤. 该系统有效地提供治疗剂,对抗耐化疗T细胞急性淋巴细胞白血病有前途.
科学领域:
- 生物医学工程 生物医学工程
- 在瘤学瘤学.
- 纳米技术 纳米技术
背景情况:
- T细胞恶性瘤的预后不好,治疗选择有限.
- 化疗耐药性是T细胞急性淋巴细胞白血病 (T-ALL) 的一个重大挑战.
- 细胞外囊泡 (EV) 具有作为药物输送载体的潜力.
研究的目的:
- 开发针对T细胞恶性瘤的向药物递送系统.
- 在T细胞急性淋巴细胞白血病中克服化疗耐药性.
- 评估装载有治疗剂的工程电动汽车的有效性和安全性.
主要方法:
- 从293T细胞中获得的工程外细胞囊 (EVs),用抗CD7单链变量片段 (αCD7/EVs) 进行修改.
- 将细胞染色体C (CytC) 和Bcl2siRNA (siBcl2) 装入αCD7/EV中,从而产生αCD7/EVs/CytC/siBcl2.
- 在人类T-ALL Molt-4细胞中测试向和内化.
- 评估对敏感细胞和耐化疗Molt-4细胞 (CR-Molt-4) 的疗效.
主要成果:
- αCD7/EVs有效准并被Molt-4细胞内部化.
- EV进入途径转移到克拉特林介导的内细胞分裂,增强治疗效果.
- αCD7/EVs/CytC/siBcl2对Molt-4和CR-Molt-4细胞都显示出显著的疗效.
- 药物输送系统显示出高安全性,低免疫性,对正常T细胞的影响最小.
结论:
- 工程化αCD7/EV是T细胞恶性瘤的有效药物输送载体.
- 该系统通过增强治疗剂的输送来克服化疗耐药性.
- αCD7/EVs/CytC/siBcl2代表了对CD7+T细胞恶性瘤的有前途的治疗策略.
相关概念视频
Cytotoxic T Cells-mediated Immune Response
844
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
844
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Tumor Immunotherapy
475
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
475


